This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.
This study will conduct a pragmatic group-randomized trial (GRT) with NHPIs aged 50-75 years with at least 1 of 4 modifiable vascular risk factors for ADRD (hypertension, hyperglycemia, obesity, or dyslipidemia) and either SCI or MCI using a wait-list control design to test the effects of the hula-based intervention. The primary outcomes will be vascular risk factors for ADRD and subjective cognitive complaints. Secondary outcomes will include measures of cognitive performance, physical function, and mental health.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
192
The first 3 months of the hula-based intervention program was designed and standardized as a culturally-based physical activity (PA) that includes 15 minutes of ADRD education and intervention orientation with 12 weeks of hula lessons. These hula lessons consist of two 60-minute classes per week over 12 weeks. Each hula lesson will consist of 8 participants, providing them with the opportunity to engage-in this social support network. For the remaining 5 months of the Ola Mau i ka Hula Program, hula lessons led by the kumu hula will be reduced to once a month for 60 min. In addition, the intervention group will meet with a community-peer educator weekly over this 5-month period. Each meeting will be 90 minutes in length with 60 minutes of hula practice following the same format as previous classes, and 30 minutes will cover the PILI Lifestyle Plan curriculum and cultural-based cognitive exercises, alternating weekly.
Kula No Na Po'e
Honolulu, Hawaii, United States
RECRUITINGKokua Kalihi Valley
Honolulu, Hawaii, United States
RECRUITINGHui No Ke Ola Pono
Wailuku, Hawaii, United States
RECRUITINGChange in participants' systolic blood pressure at each time frame from baseline
Vascular risk factor assessed using Omron©HEM-907XL
Time frame: 3 months, 8 months, 12 months
Change in participants' Hemoglobin A1c at each time frame from baseline
Vascular risk factor assessed using Alere Cholestech LDX® System
Time frame: 12 months
Change in participants' total cholesterol at each time frame from baseline
Vascular risk factor assessed using Alere Cholestech LDX® System
Time frame: 3 months, 8 months, 12 months
Change in participants' body mass index at each time frame from baseline
Vascular risk factor assessed using Tanita BWB800AS scale
Time frame: 3 months, 8 months, 12 months
Change in participants' Cognitive Change Index score at each time frame from baseline
Cognitive function assessed using Cognitive Change Index assessment
Time frame: 3 months, 8 months, 12 months
Change in participants' Number Symbol Coding Test score at each time frame from baseline
Cognitive function assessed using Number Symbol Coding Test
Time frame: 3 months, 8 months, 12 months
Change in participants' overall Cognivue score at each time frame from baseline
Cognitive function assessed using Cognivue device
Time frame: 3 months, 8 months, 12 months
Change in participants' overall Quick Dementia Rating System score at each time frame from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cognitive function assessed using Quick Dementia Rating System assessment
Time frame: 3 months, 8 months, 12 months